Virtus Fund Advisers’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Virtus Fund Advisers’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,304	Closed	-$225K	–	921
2015 Q1	$225K	Sell	1,304 -127	-9%	-$18.6K	﹤0.01%	396
2014 Q4	$164K	Hold	1,431	–	–	﹤0.01%	460
2014 Q3	$224K	Sell	1,431 -6,605	-82%	-$958K	﹤0.01%	454
2014 Q2	$991K	Buy	+8,036	New	+$888K	0.01%	455

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Virtus Fund Advisers's SLXP Position: Q2 2015 in Review

Virtus Fund Advisers sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,304 shares — an estimated $225K sold.

Virtus Fund Advisers first reported a position in SLXP in Q2 2014 and held it in 4 quarters. The position peaked at $991K in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Virtus Fund Advisers reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Virtus Fund Advisers sold 1,304 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $225K.
Virtus Fund Advisers first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2014 and held it in 4 quarters.
Virtus Fund Advisers's SALIX PHARMACEUTICALS LTD DEL position peaked at $991K in Q2 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Virtus Fund Advisers's 13F filing for Q2 2015, filed 10 Aug 2015.